Kindred Biosciences, Inc.KINNASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
0.29%
↑ 101% above average
Average (34q)
-21.26%
Historical baseline
Range
High:203.95%
Low:-238.33%
Volatility
-2080.6%
Relatively stable
| Period | Value |
|---|---|
| Q2 2021 | 0.29% |
| Q1 2021 | 14.82% |
| Q4 2020 | 10.23% |
| Q3 2020 | -152.97% |
| Q2 2020 | 203.95% |
| Q1 2020 | -47.02% |
| Q4 2019 | -2.88% |
| Q3 2019 | -6.89% |
| Q2 2019 | 10.89% |
| Q1 2019 | -3.98% |
| Q4 2018 | -18.44% |
| Q3 2018 | -15.98% |
| Q2 2018 | -12.74% |
| Q1 2018 | -2.48% |
| Q4 2017 | -23.32% |
| Q3 2017 | -16.60% |
| Q2 2017 | -4.24% |
| Q1 2017 | -11.76% |
| Q4 2016 | -2.22% |
| Q3 2016 | -14.88% |
| Q2 2016 | 18.37% |
| Q1 2016 | 5.61% |
| Q4 2015 | 9.51% |
| Q3 2015 | -3.08% |
| Q2 2015 | -2.24% |
| Q1 2015 | 0.84% |
| Q4 2014 | -11.81% |
| Q3 2014 | 25.13% |
| Q2 2014 | -31.49% |
| Q1 2014 | -50.67% |
| Q4 2013 | -238.33% |
| Q3 2013 | -205.56% |
| Q2 2013 | -76.79% |
| Q1 2013 | -87.31% |
| Q4 2012 | 0.00% |